We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Fundamental aspects
-
1. Inflammation and tissue homeostasis
- Prof. Herman Waldmann
-
2. Introduction to the immune system
- Prof. Herman Waldmann
-
3. Hematopoiesis: the making of an immune system
- Prof. Paul J. Fairchild
-
4. Inflammation: purposes, mechanisms and development
- Prof. Pietro Ghezzi
-
5. Phagocytosis
- Dr. Eileen Uribe-Querol
-
6. Regulated cell death mechanisms and their crosstalk with the immune system 1
- Dr. Luis Alberto Baena-Lopez
-
7. Regulated cell death mechanisms and their crosstalk with the immune system 2
- Dr. Luis Alberto Baena-Lopez
- Innate immunity
-
11. Cells of the innate immune system
- Prof. Kevin Maloy
-
12. Microbial recognition and the immune response
- Dr. Dana Philpott
-
13. Toll-like receptor signalling during infection and inflammation
- Prof. Luke O'Neill
- Intercellular mediators
-
14. Chemokines
- Dr. James E. Pease
-
15. Cytokines
- Prof. Iain McInnes
-
16. IL-1 family cytokines as the canonical DAMPs of the immune system
- Prof. Seamus Martin
-
17. Glycans at the frontiers of inflammation, autoimmunity and cancer
- Prof. Salomé S. Pinho
-
18. Glycoimmunology
- Prof. Paula Videira
- Adaptive immunity B cells
-
21. Antigen recognition in the immune system
- Prof. Herman Waldmann
-
22. B cell biology
- Prof. Richard Cornall
-
23. Antibody structure and function: antibody structure
- Dr. Mike Clark
-
24. Antibody structure and function: antibody function
- Dr. Mike Clark
-
25. Antibody genes and diversity
- Dr. Mike Clark
-
26. In vivo antibody discovery and hybridoma technology
- Prof. Dr. Katja Hanack
-
27. Antibody engineering: beginnings to bispecifics and beyond
- Dr. Ian Wilkinson
-
29. The immunobiology of Fc receptors
- Prof. Mark Cragg
-
30. Immunoreceptors
- Prof. Anton van der Merwe
-
31. Affinity, avidity and kinetics in immune recognition
- Prof. Anton van der Merwe
- Adaptive immunity T cells
-
32. The thymus and T cell development: a primer
- Prof. Georg Holländer
-
33. Lineage decisions in the thymus: T cell lineage commitment
- Prof. Bruno Silva-Santos
-
34. Lineage decisions in the thymus: αβ and γδ T cell lineages
- Prof. Bruno Silva-Santos
-
35. CD4 T cell subsets
- Dr. Brigitta Stockinger
-
36. Cytotoxic T lymphocytes
- Prof. Gillian M. Griffiths
-
37. Gamma delta T-cells
- Prof. Bruno Silva-Santos
-
38. Tfh and Tfr cells
- Prof. Luis Graca
-
39. Tissue resident memory T cells (TRM)
- Dr. Marc Veldhoen
-
40. Mathematical modeling in immunology
- Prof. Ruy M. Ribeiro
- The importance of the MHC in immunity
-
41. The MHC and MHC molecules 1
- Prof. Jim Kaufman
-
42. The MHC and MHC molecules 2
- Prof. Jim Kaufman
-
43. Natural killer cells
- Dr. Philippa Kennedy
-
44. Human NK cells
- Prof. Lorenzo Moretta
-
46. NK cells in viral immunity
- Prof. Lewis Lanier
- Lymphocyte activation
-
47. Signal transduction by leukocyte receptors
- Dr. Omer Dushek
-
48. Immunological memory 1
- Prof. David Gray
-
49. Immunological memory 2
- Prof. David Gray
-
50. Studying immune responses “one cell at a time”
- Dr. Mir-Farzin Mashreghi
- Major cellular partners in immunity
-
51. The mononuclear phagocyte system - tissue resident macrophages: distribution and functions
- Prof. Emeritus Siamon Gordon
-
52. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
53. Dendritic cells: professional antigen presenting cells
- Prof. Paul J. Fairchild
-
54. Mucosal immunology
- Prof. Daniel Mucida
- Immunological tolerance and regulation
-
55. Self-tolerance
- Prof. Herman Waldmann
-
56. Tolerance and autoimmunity
- Prof. Emerita Anne Cooke
-
57. The balance between intestinal immune homeostasis and inflammation
- Prof. Dr. Janneke Samsom
- Translational immunology - immune deficiency
-
58. Primary immunodeficiency disorders
- Dr. Smita Y. Patel
-
59. Changes in innate and adaptive immunity during human ageing 1
- Dr. Roel De Maeyer
-
60. Changes in innate and adaptive immunity during human ageing 2
- Dr. Roel De Maeyer
-
61. The aging immune system
- Prof. Ana Caetano
- Translational immunology - protection against pathogenic microbes
-
62. Immune responses to viruses
- Prof. Paul Klenerman
-
63. HIV and the immune system
- Prof. Quentin Sattentau
-
64. COVID-19: the anti-viral immune response
- Prof. Danny Altmann
-
65. Bacterial immune evasion
- Prof. Christoph Tang
-
66. The immunology underlying tuberculosis
- Prof. Thomas R. Hawn
-
67. Innate immunity to fungi
- Prof. Gordon D. Brown
-
68. Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
-
69. Parasite immunity: Leishmania and Schistosoma
- Dr. Catarina Gadelha
-
70. Vaccination
- Dr. Anita Milicic
-
71. The history of vaccines 1
- Prof. Emeritus Anthony R. Rees
-
72. The history of vaccines 2
- Prof. Emeritus Anthony R. Rees
-
73. The history of vaccines 3
- Prof. Emeritus Anthony R. Rees
-
74. The science of vaccine adjuvants
- Dr. Derek O'Hagan
- Translational immunology - hypersensitivity, autoimmune disease and their management
-
75. Hypersensitivity diseases: type 1 hypersensitivity
- Prof. Herman Waldmann
-
76. Innate lymphoid cells in allergy
- Prof. Emeritus Shigeo Koyasu
-
77. Hypersensitivity diseases: type II-IV hypersensitivity
- Prof. Sara Marshall
-
78. Immune memory underlying lifelong peanut allergy
- Dr. Kelly Bruton
-
79. Memory B cells in allergy: B cell activation and response
- Dr. Kelly Bruton
-
80. Memory B cells in allergy: ontogeny, phenotype and plasticity
- Dr. Kelly Bruton
-
81. B cells at the crossroads of autoimmune diseases
- Dr. Xiang Lin
-
82. Interleukin-17: from clone to clinic
- Prof. Leonie Taams
-
83. Autoimmunity and type 1 diabetes
- Prof. Emerita Anne Cooke
-
84. What is new in type 1 diabetes?
- Prof. Åke Lernmark
-
85. Antibodies to control or prevent type 1 diabetes
- Dr. Robert Hilbrands
-
86. Monoclonal antibodies in haemato-oncology
- Prof. Mark Cragg
-
87. Therapeutic antibodies
- Dr. Geoffrey Hale
-
88. Endothelial cells: regulators of autoimmune-neuroinflammation
- Dr. Laure Garnier
-
89. Neuroimmunometabolism
- Prof. Ana Domingos
-
90. The immunology of multiple sclerosis
- Dr. Joanne Jones
-
91. Immunology of the peripheral nervous system: the inflammatory neuropathies
- Dr. Simon Rinaldi
-
92. Ocular immunology: an overview of immune mechanisms operating in the eye
- Dr. Eleftherios Agorogiannis
-
93. Understanding myasthenia gravis and advances in its management
- Prof. Henry J. Kaminski
-
94. The immunology underlying rheumatic diseases
- Dr. Hussein Al-Mossawi
-
96. Complement and lupus
- Prof. Marina Botto
-
97. Immune mechanisms in liver diseases
- Prof. Paul Klenerman
- Translational immunology - transplantation immunology
-
98. Principles of transplantation: overview of the immune response
- Prof. Emerita Kathryn Wood
-
99. Factors influencing outcomes in clinical transplantation 1
- Prof. Emerita Kathryn Wood
-
100. Factors influencing outcomes in clinical transplantation 2
- Prof. Emerita Kathryn Wood
- Translational immunology - cancer immunology
-
101. Cancer immunology
- Prof. Tim Elliott
-
102. Cancer immunotherapy
- Prof. Tim Elliott
-
103. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
104. IL-2 in the immunotherapy of autoimmunity and cancer
- Prof. Thomas Malek
-
105. Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
- Dr. Else Marit Inderberg
Printable Handouts
Navigable Slide Index
- Introduction
- The MHC and MHC molecules (1)
- MHC organisation is similar (but not identical) among placental mammals
- Nomenclature for genes
- Nomenclature for alleles
- Nomenclature for haplotypes
- Nomenclature for human HLA haplotypes
- MHC haplotypes exist even in outbred humans
- MHC classical and non-classical molecules
- Historic selection is indicated by dN/dS values
- The MHC and MHC molecules (2)
- The discovery of transplantation antigens
- Mouse genetics is largely based on inbred strains
- A little bit of genetics
- Graft rejection
- Transplantation is of great medical importance
- Transplantation does not explain high MHC polymorphism
- Why have graft rejection (allo-recognition)?
- The MHC and MHC molecules (3)
- The price of a strong response to pathogens is immunopathology, autoimmunity and allergy (1)
- Association of autoimmune diseases, allergies and asthmas with classical MHC alleles
- The strongest associations of autoimmune diseases are by far with the MHC
- Disease associations using dense maps of single nucleotide polymorphisms (SNPs)
- Rheumatoid arthritis has strong associations with MHC and smoking
- Rheumatoid arthritis has strong associations with MHC and smoking (2)
- Rheumatoid arthritis arises because of T cell selection in the thymus
- Ankylosing spondylitis has strong associations with HLA-B27
- Celiac disease (gluten enteropathy) has strong associations with MHC and gluten
- In celiac disease (gluten enteropathy) tTG turns gluten peptides into DQ2 binders
- The price of a strong response to pathogens is immunopathology, autoimmunity and allergy (2)
- The MHC and MHC molecules (4)
- A long history of MHC associated with mate choice and kin recognition
- Interaction between KIR and class I molecules determines placental success (1)
- Interaction between KIR and class I molecules determines placental success (2)
- Reproduction and resistance to infectious disease depend on different KIR:MHC combinations
- The MHC and MHC molecules (5)
- A molecular arms race drives the polymorphism of MHC molecules
- MHC associations with infectious disease are weaker than with autoimmune disease
- AIDS is due to HIV infection
- Disease progression may depend on clonal exhaustion of CTLs
- The MHC is associated with disease progression
- Progression of HIV to AIDS correlates with HLA-B alleles that bind special peptides
- Tapasin-independent alleles confer slow progression to AIDS
- Heterozygous advantage and B*35-Cw04 disadvantage for resistance to AIDS
- Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
- Cell surface expression of HLA-C correlates with protection
- MHC-determined resistance to HIV progression can be due to multiple mechanisms
- Summary
Topics Covered
- Genetics, nomenclature, polymorphism, and function of MHC molecules
- Mouse genetics is largely based on inbred strains
- Transplantation and T cell selection in the thymus
- Autoimmunity, allergy, and immunopathology
- MHC and mate choice and reproduction
- MHC-determined pathogen and infectious disease resistance
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kaufman, J. (2022, May 8). The MHC and MHC molecules 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/ZZYQ7873.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commerical/financial matters to disclose.
The MHC and MHC molecules 2
Published on May 8, 2022
51 min
A selection of talks on Immunology & Inflammation
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, this is Jim Kaufman
from the University
of Edinburgh and
the University of Cambridge
with the second of
two lectures on the
MHC and MHC molecules.
0:12
In our last talk,
we defined MHC molecules
and discussed their
central role.
We considered the classical class
I and class II MHC molecules
and the non-classical MHC
molecules in some detail
and we finished with the
organisation of MHC genes
in the MHC of humans and mice.
In the second talk,
we're going to consider
more closely genetics,
nomenclature, polymorphism
and function.
Then ask the
question what drives
the high polymorphism of
classical MHC molecules?
0:45
Last time we finished
with this picture
of the human and mouse MHCs,
which are extremely complex
with hundreds of genes,
including those encoding the
classical and non-classical
MHC molecules.
Let's discuss the nomenclature,
particularly of the
classical MHC molecules.
1:05
How are these genes named?
Starting with the
classical class I genes.
For humans, these genes are
called HLA -A, B, and C.
For mouse H-2K, D, and
in some haplotypes, L.
As we mentioned last time,
these genes are due to
different expansions.
HLA-A, B, and C genes
are more closely related
to each other than they are
to any of the mouse genes.
For the classical
class II genes,
there's HLA-DRA and DRB
for the DR α and β gene,
and likewise DQA and
DQB and DPA and DPB.
In mouse, there's H2Eα and Eβ.
But unlike class I genes,
these are direct orthologs
of the human DRA and DRB.
Similarly, H-2Aα and H-2Aβ
are orthologs of DQA and DQB.
But there are no mouse
orthologs of DPA and DPB.
However, there is
a second DRB locus
in most human haplotypes.
The major one is
always called DRB1;
the others have names
like DRB3, DRB5, etc.